Abstract
Due to postoperative radiotherapy, the mean survival period of patients with malignant gliomas has been raised from 4.5 to 10.5 months (Walker et al. 1979). A combination of most thorough surgical removal of the tumor and postoperative radiotherapy (Jelsma and Bucy 1967; Sheline 1977) has become a generally recognized therapy concept. No long-term, statistically significant increase in the survival period could be achieved by raising the target dose from 60 to 80 Gy (Salazar et al. 1979), and this notion was abandoned in view of the possibility of complications (radionecroses) (Chin et al. 1986).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe M, Takahashi M (1982) Intraoperative Strahlentherapie. Strahlentherapie 158: 585–593
Burger PC, Mahaley MS, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas. A postmortem study of 25 cases. Cancer 44: 1256–1272
Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathology criteria and prognostic implications. Cancer 56: 1106–1111
Chin HW, Maruyama Y, Young B, Markesbery W, Tibbs P, Goldstein S (1986) A clinical study with brain brachytherapy for malignant gliomas. Strahlenther Onkol 162: 433–436
Csanda E (1980) Radiation brain edema. Adv Neurol 28: 125–146
Ernst H, Scheffler A, Oppel F, Brock M, Brust V, Bauer R, Pannek HW, Förster A (1986) Fraktionierte Afterloading-Bestrahlung als neues Verfahren zur Therapie inoperabler Hirntumoren. Strahlenther Onkol 162: 437440
Goldson AL, Streeter 0E, Ashayeri E, Collier-Manning J, Barber JB, Fan K-J (1984) Intraoperative radiotherapy for intracranial malignancies. Cancer 54: 2807–2813
Gutin PH, Phillips TL, Wara WM, Leibel SA, Hosobuchi Y, Levin VA, Weaver KA, Lamb S (1984) Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. J Neurosurg 60: 61–68
Hinkelbein W, Wannenmacher M (1982) The radiosensitivity of the infant brain. In: Voth D, Gutjahr P, Langmaid C (eds) Tumours of the central nervous system in infancy and childhood. Springer, Berlin Heidelberg New York, pp 291–300
Hinkelbein W, Bruggmoser G, Schmidt M, Wannenmacher M (1984) Die Kurzzeitbestrahlung des Glioblastoms mit hohen Einzelfraktionen. Strahlentherapie 160: 301–308
Jellinger K (1978) Glioblastoma multiforme: morphology and biology Acta Neurochir (Wien) 42: 5–32
Jelsma R, Bucy PC (1967) The treatment of glioblastoma multiforme of the brain. J Neurosurg 27: 388–400
Keim H, Potthoff PC, Neiss A, Trott KR (1986) Lebensqualität und Überlebenszeit von Glioblastompatienten nach accelerierter Strahlentherapie. Zentralbl Radiol 132: 372
Mundinger F (1981) Stereotaktische Therapie nicht rese-zierbarer intracranieller Tumoren mit Ir 92 und Jod125. In: Wannenmacher M, Schreiber HW, Gauwerky F (eds) Kombinierte chirurgische und radiologische Behandlung maligner Tumoren. Urban and Schwarzenberg, pp 86–108
Mundinger F (1984) Stereotaktische intrakranielle Bestrahlung von Tumoren mit Radioisotopen (Curie-Therapie). In: Dietz H, Umbach W, Wüllenweber R (eds) Klinik und Therapie. Thieme, Stuttgart pp 519–565 (Klinische Neurochirurgie, vol 2 )
Mundinger F, Weigel K (1986) Stereotactic curietherapy of thalamic tumours. In: Walker MD, Thomas DGT (eds) Biology of brain tumour. Nijhoff, Boston, pp 261–268
Ostertag CB, Groothuis D, Kleihues P (1984) Experimental data on early and late morphologic effects of permanently implanted gamma and beta sources (Ir-192, J-125 and Y-90) in the brain. Acta Neurochir [Suppl] (Wien) 33: 271–280
Salazar OM, Rubin P (1976) The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1: 627–637
Salazar OM, Rubin P, Feldstein MC, Pizzutiello R (1979) High dose radiation therapy in the treatment of malignant gliomas. Final report. Int J Radiat Oncol Biol Phys 5: 1733–1740
Schiefer W, Hasenbein B, Schmidt H (1978) Multicentric glioblastomas. Methods of diagnosis and treatment. Acta Neurochir (Wien) 42: 89–95
Sheline GE (1977) Radiation therapy of brain tumors. Cancer 39: 873–881
Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215–1228
Shin KH, Muller PI, Geggie PHS (1983) Superfractionation radiation therapy in the treatment of malignant astrocytoma. Cancer 52: 2040–2043
Simpson WJ, Platts ME (1976) Fractionation study in the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1: 639–644
Sparenberg A, Ernst H, Weigel K (1988) Fraktionierte Afterloading-therapie bei malignen, inoperablen Hirntumoren. In: Bamberg M, Sack H (eds) Therapie primärer Hirntumoren. Zuckschwerdt, Munich, pp 302–305
Thiel HJ, Huk WJ, Müller R, Sauer R (1983) Die cornputertomographisch geleitete stereotaktische interstitielle Therapie von Hirntumoren mittels temporärer oder permanenter Implantation von 125Jod-Seeds. Fortschr Geb Rontgenstr 138 (3): 348–355
Walker MD, Strike ThA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725–1731
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sparenberg, A., Weigel, K., Ernst, H. (1991). Fractionated Afterloading Therapy in the Treatment of Malignant, Inoperable Brain Tumors. In: Sauer, R. (eds) Interventional Radiation Therapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84163-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-84163-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84165-1
Online ISBN: 978-3-642-84163-7
eBook Packages: Springer Book Archive